Marianne Lomberg, ROYAL CANIN®’s Veterinary Marketing Manager, said: “Mobility problems are common, chronic and irreversible and an estimated 20 per cent of adult dogs over the age of one encounter these conditions. Untreated, a vicious cycle of progressive reduced mobility occurs and the owner sees a reduced ability to exercise and overall interactions with their pet often suffer, which may also cause dogs to become frustrated.
“Our new Mobility CP2+ᵀᴹ is a leap forward in the nutritional management of dogs with mobility issues, combining three key compounds that have a proven track record in modifying the joint environment.”
In support of the new product launch, ROYAL CANIN® also hosted a live roundtable debate at the Show on the multimodal management of cats and dogs with osteoarthritis. The recording of the debate will be available online from Wednesday 2 December, where Lee Danks, Royal Canin’s Veterinary Scientific Support Manager, will be joined by key opinion leaders Alex German, Rob Pettitt and Maria Jose Gomez Sanchez.
Visitors to ROYAL CANIN®’s stand also had the chance to experience a free demonstration of the new NATOM (‘aNATOMical map’) – an interactive educational tool designed to help the entire practice team visualise and explain cat and dog anatomy and disease conditions.